Marketplace®

Daily business news and economic stories
Feb 9, 2024

Senators grill big pharma execs on drug prices

The CEOs blamed pharmacy benefit managers, who negotiate drug prices.

Download
WASHINGTON, DC - FEBRUARY 08: U.S. Sen. Bernie Sanders (I-VT), Chairman of the Senate Health, Education, Labor, and Pensions Committee, presides over a hearing on prescription drugs costs at the Dirksen Senate Office Building on February 08, 2024 in Washington, DC. The Committee heard testimony on drug pricing from the heads of several drug manufactures including Joaquin Duato, CEO of Johnson & Johnson, Robert Davis, CEO of Merck, and Chris Boerner, CEO of Bristol Myers Squibb.
WASHINGTON, DC - FEBRUARY 08: U.S. Sen. Bernie Sanders (I-VT), Chairman of the Senate Health, Education, Labor, and Pensions Committee, presides over a hearing on prescription drugs costs at the Dirksen Senate Office Building on February 08, 2024 in Washington, DC. The Committee heard testimony on drug pricing from the heads of several drug manufactures including Joaquin Duato, CEO of Johnson & Johnson, Robert Davis, CEO of Merck, and Chris Boerner, CEO of Bristol Myers Squibb.
Kevin Dietsch/Getty Images

Subscribe:

Segments From This Episode

The Team